메뉴 건너뛰기
Neoplasma
Volumn 62, Issue 6, 2015, Pages 938-948
Inflammatory environment created by fibroblast aggregates induces growth arrest and phenotypic shift of human myeloma cells
Author keywords

Dormancy; Human multiple myeloma; Inflammation; Nemosis
Indexed keywords

CD38 ANTIGEN; CD45 ANTIGEN; SYNDECAN 1;
EID: 84969722081     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_114     Document Type: Article
Times cited : (4)
References (44)
  • 1
    • 79952781038 scopus 로고    scopus 로고
    • Multiple myeloma
    • PALUMBO A, ANDERSON K. Multiple myeloma. N Engl J Med. 2011; 364: 1046-1060. http://dx.doi.org/10.1056/ NEJMra1011442
    • (2011) N Engl J Med. , vol.364 , pp. 1046-1060
    • Palumbo, A.1    Anderson, K.2
  • 2
    • 0344142354 scopus 로고    scopus 로고
    • Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
    • PMID: 9920853
    • GARCIA-SANZ R, ORFAO A, GONZALEZ M, TABERNERO MD, BLADE J et al. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 1999; 93: 1032-1037. PMID: 9920853.
    • (1999) Blood , vol.93 , pp. 1032-1037
    • Garcia-Sanz, R.1    Orfao, A.2    Gonzalez, M.3    Tabernero, M.D.4    Blade, J.5
  • 3
    • 27144493396 scopus 로고    scopus 로고
    • Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma
    • NOWAKOWSKI GS, WITZIG TE, DINGLI D, TRACZ MJ, GERTZ MA et al. Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma. Blood 2005; 106: 2276-2279. http://dx.doi.org/10.1182/blood-2005-05- 1858
    • (2005) Blood , vol.106 , pp. 2276-2279
    • Nowakowski, G.S.1    Witzig, T.E.2    Dingli, D.3    Tracz, M.J.4    Gertz, M.A.5
  • 4
    • 84892495770 scopus 로고    scopus 로고
    • Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
    • PAIVA B, PAINO T, SAYAGUES JM, GARAYOA M, SANSEGUNDO L et al. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. Blood 2013; 122: 3591-3598. http://dx.doi.org/10.1182/blood-2013-06-510453
    • (2013) Blood , vol.122 , pp. 3591-3598
    • Paiva, B.1    Paino, T.2    Sayagues, J.M.3    Garayoa, M.4    Sansegundo, L.5
  • 5
    • 84868565193 scopus 로고    scopus 로고
    • Extramedullary involvement in multiple myeloma
    • BLADE J, DE LARREA CF, ROSINOL L. Extramedullary involvement in multiple myeloma. Haematologica 2012; 97: 1618-1619. http://dx.doi.org/10.3324/ haematol.2012.078519
    • (2012) Haematologica , vol.97 , pp. 1618-1619
    • Blade, J.1    De Larrea, C.F.2    Rosinol, L.3
  • 6
    • 80053621178 scopus 로고    scopus 로고
    • Soft-tissue plasmacytomas in multiple myeloma: Incidence, mechanisms of extramedullary spread, and treatment approach
    • BLADE J, FERNANDEZ DE LARREA C, ROSINOL L, CIBEIRA MT, JIMENEZ R et al. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol. 2011; 29: 3805-3812. http://dx.doi.org/10.1200/JCO.2011.34.9290
    • (2011) J Clin Oncol. , vol.29 , pp. 3805-3812
    • Blade, J.1    Fernandez De Larrea, C.2    Rosinol, L.3    Cibeira, M.T.4    Jimenez, R.5
  • 7
    • 84863581473 scopus 로고    scopus 로고
    • Myeloma as a model for the process of metastasis: Implications for therapy
    • GHOBRIAL IM. Myeloma as a model for the process of metastasis: implications for therapy. Blood 2012; 120: 20-30. http://dx.doi.org/10.1182/blood-2012-01-379024
    • (2012) Blood , vol.120 , pp. 20-30
    • Ghobrial, I.M.1
  • 8
    • 84868559107 scopus 로고    scopus 로고
    • Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents
    • USMANI SZ, HEUCK C, MITCHELL A, SZYMONIFKA J, Nair B et al. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica 2012; 11: 1761-1767. http://dx.doi.org/10.3324/ haematol.2012.065698
    • (2012) Haematologica , vol.11 , pp. 1761-1767
    • Usmani, S.Z.1    Heuck, C.2    Mitchell, A.3    Szymonifka, J.4    Nair, B.5
  • 9
    • 84892428493 scopus 로고    scopus 로고
    • Extramedullary myeloma spread triggered by surgical procedures: An emerging entity?
    • ROSINOL L, FERNANDEZ DE LARREA C, BLADE J. Extramedullary myeloma spread triggered by surgical procedures: an emerging entity? Acta Haematol. 2014; 132: 36-38. http://dx.doi.org/10.1159/000354833
    • (2014) Acta Haematol. , vol.132 , pp. 36-38
    • Rosinol, L.1    Fernandez De Larrea, C.2    Blade, J.3
  • 10
    • 47949099098 scopus 로고    scopus 로고
    • Origin and physiological roles of inflammation
    • MEDZHITOV R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435. http://dx.doi.org/10.1038/ nature07201
    • (2008) Nature , vol.454 , pp. 428-435
    • Medzhitov, R.1
  • 11
    • 84879151676 scopus 로고    scopus 로고
    • Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexam- ethasone therapy in multiple myeloma
    • HARADA T, OZAKI S, ODA A, FUJI S, NAKAMURA S et al. Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexam- ethasone therapy in multiple myeloma. Int J Hematol. 2013; 97: 743-748. http://dx.doi.org/10.1007/s12185-013- 1321-0
    • (2013) Int J Hematol. , vol.97 , pp. 743-748
    • Harada, T.1    Ozaki, S.2    Oda, A.3    Fuji, S.4    Nakamura, S.5
  • 12
    • 77955906264 scopus 로고    scopus 로고
    • The nuclear factor NF-kappaB pathway in inflammation
    • LAWRENCE T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009; 1: a001651. http://dx.doi.org/10.1101/cshperspect.a001651
    • (2009) Cold Spring Harb Perspect Biol. , vol.1
    • Lawrence, T.1
  • 13
    • 34547562418 scopus 로고    scopus 로고
    • Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma
    • PMID: 17692804
    • ANNUNZIATA CM, DAVIS RE, DEMCHENKO Y, BELLAMY W, GABREA A. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12: 115-130. PMID: 17692804 http://dx.doi.org/10.1016/j. ccr.2007.07.004
    • (2007) Cancer Cell , vol.12 , pp. 115-130
    • Annunziata, C.M.1    Davis, R.E.2    Demchenko, Y.3    Bellamy, W.4    Gabrea, A.5
  • 14
    • 34547660308 scopus 로고    scopus 로고
    • Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma
    • PMID: 17692805
    • KEATS JJ, FONSECA R, CHESI M, SCHOP R, BAKER A. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131-144. PMID: 17692805 http://dx.doi.org/10.1016/j. ccr.2007.07.003
    • (2007) Cancer Cell , vol.12 , pp. 131-144
    • Keats, J.J.1    Fonseca, R.2    Chesi, M.3    Schop, R.4    Baker, A.5
  • 15
    • 84926205248 scopus 로고    scopus 로고
    • Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report
    • PALUMBO A, BRINGHEN S, MATEOS MV, LAROCCA A, FACON T et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood 2015; 125: 2068-2074. http://dx.doi.org/10.1182/blood-2014-12-615187
    • (2015) Blood , vol.125 , pp. 2068-2074
    • Palumbo, A.1    Bringhen, S.2    Mateos, M.V.3    Larocca, A.4    Facon, T.5
  • 16
    • 77952294609 scopus 로고    scopus 로고
    • The sterile inflammation response
    • ROCK LK, LATZ E, ONTIVEROS F, KONO H. The sterile inflammation response. Annu Rev Immunol. 2010; 28: 321-342. http://dx.doi.org/10.1146/annurev-immunol- 030409-101311
    • (2010) Annu Rev Immunol. , vol.28 , pp. 321-342
    • Rock, L.K.1    Latz, E.2    Ontiveros, F.3    Kono, H.4
  • 17
    • 84857141296 scopus 로고    scopus 로고
    • Cancer-related inflammation: Common themes and therapeutic opportunities
    • BALKWILL FR, MANTOVANI A. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin Cancer Biol. 2012; 22: 33-40. http://dx.doi.org/10.1016/j. semcancer.2011.12.005
    • (2012) Semin Cancer Biol. , vol.22 , pp. 33-40
    • Balkwill, F.R.1    Mantovani, A.2
  • 18
    • 27544498809 scopus 로고    scopus 로고
    • Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasive-ness
    • KANKURI E, CHOLUJOVA D, COMAJOVA M, VAHERI, A, BIZIK J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasive-ness. Cancer Res. 2005; 65: 9914-9922. http://dx.doi. org/10.1158/0008-5472.CAN-05-1559
    • (2005) Cancer Res. , vol.65 , pp. 9914-9922
    • Kankuri, E.1    Cholujova, D.2    Comajova, M.3    Vaheri, A.4    Bizik, J.5
  • 19
    • 0742289480 scopus 로고    scopus 로고
    • Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression
    • BIZIK J, KANKURI E, RISTIMAKI A, TAIEB A, VAPAATALO H et al. Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ. 2004; 11: 183-195. http://dx.doi.org/10.1038/sj.cdd.4401317
    • (2004) Cell Death Differ. , vol.11 , pp. 183-195
    • Bizik, J.1    Kankuri, E.2    Ristimaki, A.3    Taieb, A.4    Vapaatalo, H.5
  • 20
    • 39649093872 scopus 로고    scopus 로고
    • Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells
    • KANKURI E, BABUSIKOVA O, HLUBINOVA K, SALMENPERA P, BOCCACCIO C et al. Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells. Int J Cancer 2008; 122: 1243-1252. http://dx.doi.org/10.1002/ ijc.23179
    • (2008) Int J Cancer , vol.122 , pp. 1243-1252
    • Kankuri, E.1    Babusikova, O.2    Hlubinova, K.3    Salmenpera, P.4    Boccaccio, C.5
  • 21
    • 0014863885 scopus 로고
    • Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient
    • PMID: 4097745
    • NILSSON K, BENNICH H, JOHANSSON SG, PONTEN J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol. 1970; 7: 477-489. PMID: 4097745
    • (1970) Clin Exp Immunol. , vol.7 , pp. 477-489
    • Nilsson, K.1    Bennich, H.2    Johansson, S.G.3    Ponten, J.4
  • 22
    • 0014115428 scopus 로고
    • Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma
    • MATSUOKA Y, MOORE GE, YAGI Y, PRESSMAN D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med. 1967; 125: 1246-1250. http://dx.doi.org/10.3181/00379727-125-32327
    • (1967) Proc Soc Exp Biol Med. , vol.125 , pp. 1246-1250
    • Matsuoka, Y.1    Moore, G.E.2    Yagi, Y.3    Pressman, D.4
  • 23
    • 0024503978 scopus 로고
    • The human myeloma cell line LP-1: A versatile model in which to study early plasma-cell differentiation and c-myc activation
    • PMID: 2784066
    • PEGORARO L, MALAVASI F, BELLONE G, MASSAIA M, BOCCADORO M et al. The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood 1989; 73: 1020-1027. PMID: 2784066
    • (1989) Blood , vol.73 , pp. 1020-1027
    • Pegoraro, L.1    Malavasi, F.2    Bellone, G.3    Massaia, M.4    Boccadoro, M.5
  • 24
    • 84925730600 scopus 로고    scopus 로고
    • The epigenetic/noncoding origin of tumor dormancy
    • CREA F, NUR SAIDY NR, COLLINS CC, WANG Y. The epigenetic/noncoding origin of tumor dormancy. Trends Mol Med. 2015; 21: 206-211. http://dx.doi.org/10.1016/j.molmed.2015.02.005
    • (2015) Trends Mol Med. , vol.21 , pp. 206-211
    • Crea, F.1    Nur Saidy, N.R.2    Collins, C.C.3    Wang, Y.4
  • 25
    • 77950799458 scopus 로고    scopus 로고
    • Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders
    • RAJA KR, KOVAROVA L, HAJEK R. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders. Br J Haematol. 2010; 149: 334-351. http://dx.doi. org/10.1111/j.1365-2141.2010.08121.x
    • (2010) Br J Haematol. , vol.149 , pp. 334-351
    • Raja, K.R.1    Kovarova, L.2    Hajek, R.3
  • 26
    • 84870039787 scopus 로고    scopus 로고
    • Can we change the disease biology of multiple myeloma?
    • BORRELLO I. Can we change the disease biology of multiple myeloma? Leuk Res. 2012; 36 Suppl 1: S3-12. http://dx.doi. org/10.1016/S0145-2126(12)70003-6
    • (2012) Leuk Res. , vol.36 , pp. S3-S12
    • Borrello, I.1
  • 27
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • HANAHAN D, WEINBERG RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674. http://dx.doi. org/10.1016/j.cell.2011.02.013
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 28
    • 33744479425 scopus 로고    scopus 로고
    • Inflammation and multiple myeloma: The Toll connection
    • MANTOVANI A, GARLANDA C. Inflammation and multiple myeloma: the Toll connection. Leukemia 2006; 20: 937-938. http://dx.doi.org/10.1038/sj.leu.2404229
    • (2006) Leukemia , vol.20 , pp. 937-938
    • Mantovani, A.1    Garlanda, C.2
  • 29
    • 84902160686 scopus 로고    scopus 로고
    • Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma
    • LEE H, KONG SY, SOHN JY, SHIM H, Youn HS et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Biomed Res Int. 2014; 2014: Article ID 145619. http://dx.doi. org/10.1155/2014/145619
    • (2014) Biomed Res Int.
    • Lee, H.1    Kong, S.Y.2    Sohn, J.Y.3    Shim, H.4    Youn, H.S.5
  • 30
    • 84921718378 scopus 로고    scopus 로고
    • Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: Implications for redefining high-risk myeloma
    • GONSALVES WI, RAJKUMAR SV, GUPTA V, MORICE WG, TIMM MM et al. Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma. Leukemia 2014; 28: 2060-2065. http://dx.doi.org/10.1038/leu.2014.98
    • (2014) Leukemia , vol.28 , pp. 2060-2065
    • Gonsalves, W.I.1    Rajkumar, S.V.2    Gupta, V.3    Morice, W.G.4    Timm, M.M.5
  • 31
    • 77958538665 scopus 로고    scopus 로고
    • History of leukemia-lym- phoma cell lines
    • DREXLER HG, MACLEOD RA. History of leukemia-lym- phoma cell lines. Hum Cell. 2010; 3: 75-82. http: //dx.doi. org/10.1111/j.1749-0774.2010.00087
    • (2010) Hum Cell. , vol.3 , pp. 75-82
    • Drexler, H.G.1    Macleod, R.A.2
  • 32
    • 84882986288 scopus 로고    scopus 로고
    • Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma
    • MOSCHETTA M, BASILE A, FERRUCCI A, FRASSANITO MA, RAO L et al. Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma. Clin Cancer Res. 2013; 19: 4371-4382. http://dx.doi.org/10.1158/1078-0432.CCR-13-0039
    • (2013) Clin Cancer Res. , vol.19 , pp. 4371-4382
    • Moschetta, M.1    Basile, A.2    Ferrucci, A.3    Frassanito, M.A.4    Rao, L.5
  • 33
    • 84870417566 scopus 로고    scopus 로고
    • Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth
    • PFEIFER S, SCHREDER M, BOLOMSKY A, GRAFFI S, FUCHS D et al. Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth. J Cancer Res Clin Oncol. 2012; 138: 1821-1830. http://dx.doi. org/10.1007/s00432-012-1259-2
    • (2012) J Cancer Res Clin Oncol. , vol.138 , pp. 1821-1830
    • Pfeifer, S.1    Schreder, M.2    Bolomsky, A.3    Graffi, S.4    Fuchs, D.5
  • 34
    • 8844219644 scopus 로고    scopus 로고
    • PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells
    • LENTZSCH S, CHATTERJEE M, GRIES M, BOMMERT K, GOLLASCH H et al. PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 2004; 18: 1883-1890. http:// dx.doi.org/10.1038/sj.leu.2403486
    • (2004) Leukemia , vol.18 , pp. 1883-1890
    • Lentzsch, S.1    Chatterjee, M.2    Gries, M.3    Bommert, K.4    Gollasch, H.5
  • 35
    • 35848951634 scopus 로고    scopus 로고
    • DNA damage and cellular differentiation: More questions than responses
    • SIMONATTO M, LATELLA L, PURI PL. DNA damage and cellular differentiation: more questions than responses. J Cell Physiol. 2007; 213: 642-648. http://dx.doi.org/10.1002/ jcp.21275
    • (2007) J Cell Physiol. , vol.213 , pp. 642-648
    • Simonatto, M.1    Latella, L.2    Puri, P.L.3
  • 36
    • 67349092202 scopus 로고    scopus 로고
    • Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6
    • DEZORELLA N, PEVSNER-FISHER M, DEUTSCH V, KAY S, BARON S et al. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6. Exp Cell Res. 2009; 315: 1904-1913. http://dx.doi.org/10.1016/j.yexcr.2009.03.016
    • (2009) Exp Cell Res. , vol.315 , pp. 1904-1913
    • Dezorella, N.1    Pevsner-Fisher, M.2    Deutsch, V.3    Kay, S.4    Baron, S.5
  • 37
    • 27744526844 scopus 로고    scopus 로고
    • The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient and apoptosis-resistant phenotype
    • YACCOBY S. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient and apoptosis-resistant phenotype. Clin Cancer Res. 2005; 11: 7599-7606. http://dx.doi.org/10.1158/1078-0432. CCR-05-0523
    • (2005) Clin Cancer Res. , vol.11 , pp. 7599-7606
    • Yaccoby, S.1
  • 38
    • 84887611170 scopus 로고    scopus 로고
    • Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma
    • HAJEK R, OKUBOTE SA, SVACHOVA H. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma. Br J Haematol. 2013; 163: 551-564. http://dx.doi. org/10.1111/bjh.12563
    • (2013) Br J Haematol. , vol.163 , pp. 551-564
    • Hajek, R.1    Okubote, S.A.2    Svachova, H.3
  • 39
    • 84872008395 scopus 로고    scopus 로고
    • Cell plasticity and heterogeneity in cancer
    • MARJANOVIC ND, WEINBERG RA, CHAFFER CL. Cell plasticity and heterogeneity in cancer. Clin Chem. 2013; 59: 168-179. http://dx.doi.org/10.1373/clinchem.2012.184655
    • (2013) Clin Chem. , vol.59 , pp. 168-179
    • Marjanovic, N.D.1    Weinberg, R.A.2    Chaffer, C.L.3
  • 40
    • 79961027391 scopus 로고    scopus 로고
    • Treatment of multiple myeloma
    • RAJKUMAR SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 2011; 8: 479-491. http://dx.doi.org/10.1038/ nrclinonc.2011.63
    • (2011) Nat Rev Clin Oncol. , vol.8 , pp. 479-491
    • Rajkumar, S.V.1
  • 41
    • 84873565928 scopus 로고    scopus 로고
    • Minor clone provides a reservoir for relapse in multiple myeloma
    • MAGRANGEAS F, AVET-LOISEAU H, GOURAUD W, LODE L, DECAUX O et al. Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia 2013; 27: 473-481. http://dx.doi.org/10.1038/leu.2012.226
    • (2013) Leukemia , vol.27 , pp. 473-481
    • Magrangeas, F.1    Avet-Loiseau, H.2    Gouraud, W.3    Lode, L.4    Decaux, O.5
  • 42
    • 84869089863 scopus 로고    scopus 로고
    • Minimal residual disease in myeloma: Are we there yet?
    • HART AJ, JAGASIA MH, KIM AS, MOSSE CA. et al. Minimal residual disease in myeloma: are we there yet? Biol Blood Marrow Transplant. 2012; 18: 1790-1799. http://dx.doi. org/10.1016/j.bbmt.2012.05.009
    • (2012) Biol Blood Marrow Transplant. , vol.18 , pp. 1790-1799
    • Hart, A.J.1    Jagasia, M.H.2    Kim, A.S.3    Mosse, C.A.4
  • 43
    • 84928828457 scopus 로고    scopus 로고
    • Minimal residual disease in multiple myeloma: Bringing the bench to the bedside
    • MAILANKODY S, KORDE N, LESOKHIN AM, LENDVAI AM, HASSOUN H et al. Minimal residual disease in multiple myeloma: bringing the bench to the bedside. Nat Rev Clin Oncol. 2015; 12: 286-295. http://dx.doi.org/10.1038/ nrclinonc.2014.239
    • (2015) Nat Rev Clin Oncol. , vol.12 , pp. 286-295
    • Mailankody, S.1    Korde, N.2    Lesokhin, A.M.3    Lendvai, A.M.4    Hassoun, H.5
  • 44
    • 35548958882 scopus 로고    scopus 로고
    • Tumor cell dormancy: An NCI workshop report
    • VESSELLA RL, PANTEL K, MOHLA S. Tumor cell dormancy: an NCI workshop report. Cancer Biol Ther. 2007; 6: 1496-504. http://dx.doi.org/10.4161/cbt.6.9.4828
    • (2007) Cancer Biol Ther. , vol.6 , pp. 1496-1504
    • Vessella, R.L.1    Pantel, K.2    Mohla, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.